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Introduction
Splenic “incidentalomas” are focal lesions of the spleen
that are discovered on imaging studies that were per-
formed for the evaluation of non-spleen related pathol-
ogy. These lesions are frequently encountered on CT and
ultrasound examinations. Most incidental focal splenic
lesions are benign, however a systematic approach to
evaluating these lesions is important, because many
benign and malignant splenic masses share common
imaging features [1,2].
The odds
Small studies report the prevalence of incidental splenic
lesions on CT scans performed on trauma patients to be
less than 1.5% [2]. Metastases and lymphoma are the
two most common splenic malignancies, and although
both are very rarely seen in the setting of an incidental
finding. There are only a few dozen reports of isolated
splenic metastases in the literature, so incidental splenic
lesions without any evidence of metastases elsewhere
are unlikely to be metastatic [3]. Similarly, most splenic
lymphomas are seen in patients with systemic disease,
and evidence of lymphoma can be found elsewhere on
the scan.
Morphologic clues
Asymptomatic simple cysts are almost always benign;
these are most commonly false cysts due to prior hema-
toma or infarct, as well as true congenital epidermoid
cysts and pancreatic pseudocysts. Abscesses, echinococcal
cysts, cystic metastases, and lymphoma can manifest as
simple cysts, but these are not usually incidental; there is
usually a typical history, and there are usually other clues
on the study. In any event, these more commonly cause
complex appearing cysts. Patients with splenic abscesses
are almost always febrile and symptomatic. Abnormal
enhancement patterns suggest malignant etiologies such
as metastases, lymphoma, and angiosarcoma. Hypervascu-
lar masses are frequently due to benign masses such as
hemangiomas, hamartomas, littoral cell angiomas, and
lymphangiomas, but hypervascular metastases and lym-
phoma must be considered. Angiosarcomas are rare, and
cause irregular hypervascular masses. The differential diag-
nosis of multiple small hypovascular masses includes gran-
ulomatous disease, metastases, and lymphoma.
Most calcifications are benign, but several morpholo-
gical forms may be associated with malignancy or
infection.
Workup
Lesions with specific benign features, such as a simple
cyst in an asymptomatic patient may be dismissed. Prior
imaging and history are the key to evaluating indetermi-
nate lesions such as small hypovascular masses. Stable
lesions for one year or greater in patients without cancer
are benign; if no prior examinations are available then
indeterminate lesions in asymptomatic patients should be
followed. If there is a history of lymphoma or other can-
cer, MRI or PET scan should be considered. The most
common indication for percutaneous splenic biopsy is an
indeterminate splenic mass in a patient with history of
lymphoma or other malignancy [4]. Published guidelines,
such as those formulated by the American College of
Radiology committee on splenic and nodal findings can
be extremely useful in approaching these common
lesions [1].
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